[{"Assets_0_Q1_USD":351861000.0,"CommonStockSharesOutstanding_0_Q1_shares":37642000.0,"EarningsPerShareBasic_1_Q1_USD":-0.32,"EarningsPerShareDiluted_1_Q1_USD":-0.32,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18008000.0,"NetIncomeLoss_1_Q1_USD":-12236000.0,"StockholdersEquity_0_Q1_USD":87054000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":38559000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":38559000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180504"}]